PBA
Paradigm Biocapital Advisors’s Vor Biopharma VOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,457,293
| Closed | -$6.46M | – | 39 |
|
|
2024
Q2 | $6.46M | Hold |
6,457,293
| – | – | 0.25% | 33 |
|
|
2024
Q1 | $15.3M | Hold |
6,457,293
| – | – | 0.54% | 29 |
|
|
2023
Q4 | $14.5M | Sell |
6,457,293
-4,174
| -0.1% | -$9.39K | 0.68% | 26 |
|
|
2023
Q3 | $13.7M | Hold |
6,461,467
| – | – | 0.93% | 25 |
|
|
2023
Q2 | $20M | Sell |
6,461,467
-16,532
| -0.3% | -$51.1K | 1.54% | 24 |
|
|
2023
Q1 | $34.9M | Buy |
6,477,999
+35,174
| +0.5% | +$189K | 3.3% | 17 |
|
|
2022
Q4 | $42.8M | Buy |
6,442,825
+4,739,180
| +278% | +$31.5M | 5.03% | 10 |
|
|
2022
Q3 | $6.78M | Buy |
1,703,645
+399,345
| +31% | +$1.59M | 0.9% | 26 |
|
|
2022
Q2 | $6.48M | Buy |
1,304,300
+409,896
| +46% | +$2.04M | 1.29% | 19 |
|
|
2022
Q1 | $5.4M | Buy |
894,404
+265,062
| +42% | +$1.6M | 1.43% | 21 |
|
|
2021
Q4 | $7.31M | Buy |
+629,342
| New | +$7.31M | 2.09% | 19 |
|